Article Details

AstraZeneca buys CinCor in a deal worth up to $1.8B - PharmaLive

Retrieved on: 2023-01-09 14:30:47

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buys CinCor in a deal worth up to $1.8B - PharmaLive. View article details on HISWAI: https://www.pharmalive.com/astrazeneca-buys-cincor-in-a-deal-worth-up-to-1-8b/

Excerpt

AstraZeneca will gain the rights to CinCor's aldosterone synthase inhibitor candidate baxdrostat through this transaction. Baxdrostat is being ...

Article found on: www.pharmalive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up